Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Zimmer Biomet shows steady sales growth amid transformation and debt challenges
ZBH
$100.05
+$0.01 +0.01%

Zimmer Biomet shows steady sales growth amid transformation and debt challenges

Market News
01 Sep 2026
Seeking Alpha
View Source
Bullish
pluang ai news

Zimmer Biomet is experiencing steady sales growth driven by transformation efforts, research and development, and mergers and acquisitions. However, earnings growth has been slower to catch up with sales. This growth is important as the company manages a significant debt load, with potential for stock re-rating if earnings improve. Shares have rebounded to around $100 after dipping to the mid-$80s earlier in the year.

More News (ZBH)

Zimmer Biomet declares $0.24 quarterly dividend payable October 30, 2026

Zimmer Biomet declares $0.24 quarterly dividend payable October 30, 2026

Zimmer Biomet Holdings announced a quarterly cash dividend of $0.24 per share for Q3 2026. The dividend will be paid on or about October 30, 2026, to shareholders of record as of September 30, 2026. This move reflects Zimmer Biomet's ongoing commitme...

Company Fundamentals
Bullish
3 days ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App